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We describe an assay for transposase-accessible chromatin using sequencing (AtAc-seq), based on direct in vitro transposition of sequencing adaptors into native chromatin, as a rapid and sensitive method for integrative epigenomic analysis. AtAc-seq captures open chromatin sites using a simple two-step protocol with 500-50,000 cells and reveals the interplay between genomic locations of open chromatin, dnA-binding proteins, individual nucleosomes and chromatin compaction at nucleotide resolution. We discovered classes of dnA-binding factors that strictly avoided, could tolerate or tended to overlap with nucleosomes. using AtAc-seq maps of human cd4 + t cells from a proband obtained on consecutive days, we demonstrated the feasibility of analyzing an individual's epigenome on a timescale compatible with clinical decision-making.
Eukaryotic genomes are hierarchically packaged into chromatin 1 , and the nature of this packaging plays a central role in gene regulation 2, 3 . Major insights into the epigenetic information encoded within the nucleoprotein structure of chromatin have come from high-throughput, genome-wide methods for separately assaying chromatin accessibility ('open chromatin') 4, 5 , nucleosome positioning [6] [7] [8] and transcription factor (TF) occupancy 9 . Though they are powerful, published protocols for existing methods require millions of cells as starting material, involve complex and timeconsuming sample preparations, and cannot probe the interplay of nucleosome positioning, chromatin accessibility and TF binding simultaneously. These limitations give rise to three shortcomings. First, current methods can average over and 'drown out' heterogeneity in cellular populations. Second, cells must often be grown ex vivo to obtain sufficient material, and such conditions perturb the in vivo context and modulate the epigenetic state in unknown ways. Third, input requirements often prevent application of these assays to well-defined clinical samples, thereby precluding generation of 'personal epigenomes' on diagnostic timescales.
Here we report a robust and sensitive method for epigenomic profiling that can provide a multidimensional portrait of gene 
AtAc-seq probes chromatin accessibility with transposomes
Hyperactive Tn5 transposase 10, 11 , loaded in vitro with adaptors for high-throughput DNA sequencing, can simultaneously fragment and tag a genome with sequencing adaptors (previously described as "tagmentation" 11 ). Because transposons have been shown to integrate into active regulatory elements in vivo 12 , we hypothesized that transposition by purified Tn5, a prokaryotic transposase, on small numbers of unfixed eukaryotic nuclei would interrogate regions of accessible chromatin. In ATAC-seq, Tn5 transposase integrates its adaptor payload into regions of accessible chromatin, whereas steric hindrance in less accessible chromatin makes such transposition less probable. Therefore, amplifiable DNA fragments suitable for high-throughput sequencing are preferentially generated at locations of open chromatin (Fig. 1a) . The entire assay and library construction can be carried out in a simple protocol involving Tn5 insertion followed by PCR. In contrast, published DNase-seq and formaldehyde-assisted isolation of regulatory elements with sequencing (FAIRE-seq) methods for assaying chromatin accessibility involve multistep protocols 13, 14 and many potentially loss-prone steps, such as adaptor ligation, gel purification and cross-link reversal.
We carried out ATAC-seq on sets of 50,000 and 500 unfixed nuclei isolated from the GM12878 human lymphoblastoid cell line (Encyclopedia of DNA Elements (ENCODE) Tier 1; ref. 15) for comparison and validation with chromatin-accessibility data sets, including DNase-seq 13 and FAIRE-seq 16 , which were generated from 1-50 million cells (Fig. 1b) . At a locus previously highlighted by others 5 (Fig. 1c) , ATAC-seq had a signal-to-noise ratio similar to that of DNase-seq, whose data were generated from ~3-5 orders of magnitude more cells 13 . Peak intensities were highly reproducible between technical replicates (R = 0.98) and highly correlated between ATAC-seq and two different sources of DNase-seq data (R = 0.79 and R = 0.83; Supplementary Fig. 1) , and the majority of reads within peaks came from intersections of DNase and ATAC-seq peaks (Supplementary Fig. 2) . We compared our data to DNase-hypersensitive sites identified in ENCODE DNase-seq data: receiver operating characteristic curves demonstrated a similar sensitivity and specificity for ATAC-seq and DNase-seq (Supplementary Fig. 3 ). ATAC-seq peak intensities also correlated well with markers of active chromatin and not with transposase sequence preference ( Supplementary Figs. 4  and 5) . Highly sensitive open-chromatin detection was maintained even when using 5,000 or 500 human nuclei as starting material (Supplementary Figs. 3 and 6) , although sensitivity was diminished for smaller numbers of input material.
AtAc-seq insert sizes disclose nucleosome positions
We found that ATAC-seq paired-end reads produced detailed information about nucleosome packing and positioning. The insert size distribution of sequenced fragments from human chromatin had clear periodicity of approximately 200 bp, suggesting many fragments are protected by integer multiples of nucleosomes (Fig. 2a) . This fragment size distribution also showed clear periodicity equal to the helical pitch of DNA 11 . By partitioning the insert size distribution according to functional classes of chromatin as defined by previous models 17 and normalizing to the global insert distribution (Online Methods), we observed clear class-specific enrichments across this insert size distribution (Fig. 2b) . This result demonstrated that these functional states of chromatin have an accessibility fingerprint that can be read out with ATAC-seq. The differential fragmentation patterns were consistent with the putative functional state of these classes: CCCTC-binding factor (CTCF)-bound regions were enriched for short fragments of DNA, whereas transcription start sites (TSSs) were differentially depleted for mono-, di-and trinucleosome-associated fragments. Transcribed and promoterflanking regions were enriched for longer multinucleosomal fragments, a result suggesting that such regions represent a form of chromatin that is less accessible than that of TSSs. Finally, prior studies have shown that certain DNA sequences are refractory to No. of cells 10 npg nuclease digestion and are released as large, multinucleosomesized fragments 18 ; subsequent studies showed that such fragments are condensed heterochromatin 19 . Indeed we found that repressed, untranscribed regions (as defined by the chromatin state model) are depleted for short fragments and enriched for phased multinucleosomal inserts, which is consistent with their expected inaccessible state. These data suggest that ATAC-seq reveals differentially accessible forms of chromatin, which have been long hypothesized to exist in vivo 2, 20, 21 .
To explore nucleosome positioning within accessible chromatin in the GM12878 cell line, we partitioned our data into reads generated from putative nucleosome-free regions of DNA and reads likely derived from nucleosome-associated DNA (Online Methods and Supplementary Fig. 7) . Using a simple heuristic that positively weights nucleosome-associated fragments and negatively weights nucleosome-free fragments (Online Methods), we calculated a data track used to call nucleosome positions within regions of accessible chromatin 22 . An example locus (Fig. 3a) contains a putative bidirectional promoter with cap analysis of gene expression (CAGE) data showing two TSSs separated by ~700 bp. ATAC-seq revealed in fact two distinct nucleosome-free regions separated by a single well-positioned mononucleosome (Fig. 3a) . Compared to micrococcal nuclease digestion followed by sequencing (MNase-seq) 23 data, ATAC-seq data were more amenable to detecting nucleosomes within putative regulatory regions, as the majority of reads were concentrated within accessible regions of chromatin (Fig. 3b) . By averaging signal across all active TSSs, we found that nucleosome-free fragments were enriched at a canonical nucleosome-free promoter region overlapping the TSS, whereas our nucleosome signal was (Fig. 3c) . Because ATAC-seq reads are concentrated at regions of open chromatin, we saw a strong nucleosome signal at the +1 nucleosome that decreased at the +2, +3 and +4 nucleosomes. In contrast, MNase-seq nucleosome signal increased at larger distances from the TSS, likely owing to overdigestion of more accessible nucleosomes. Additionally, MNase-seq (4 billion reads) assays all nucleosomes, whereas reads generated from ATAC-seq (198 million paired reads) are concentrated at regulatory nucleosomes (Fig. 3b,c) . Using our nucleosome calls, we further partitioned putative distal regulatory regions and TSSs into regions that were nucleosome free and regions that were predicted to be nucleosome bound. We note that TSSs were enriched for nucleosome-free regions when compared to distal elements, which tend to remain nucleosome rich (Fig. 3d) . These data suggest ATAC-seq can provide high-resolution readouts of nucleosome-associated and nucleosome-free regions in regulatory elements genome wide.
AtAc-seq reveals patterns of nucleosome-tF spacing
Using chromatin immunoprecipitation followed by sequencing (ChIP-seq) data, we plotted the position of a variety of DNAbinding factors with respect to the dyad of the nearest nucleosome derived from ATAC-seq data. Unsupervised hierarchical clustering (Fig. 3e) revealed major classes of binding with respect to the proximal nucleosome, including (i) a strongly nucleosome-avoiding group of factors with binding events stereotyped at ~180 bases from the nearest nucleosome dyad (comprising C-FOS, NFYA and IRF3), (ii) a class of factors that 'nestle up' next to the expected end of nucleosome DNA contacts, which notably includes chromatin looping factor CTCF and cohesin-complex subunits RAD21 and SMC3, (iii) a large class primarily of TFs that have gradations of nucleosome-avoiding or nucleosome-overlapping binding behavior and (iv) a class whose binding sites tend to overlap nucleosome-associated DNA. Interestingly, this final class includes chromatin-remodeling factors such as CHD1 and SIN3A as well as RNA polymerase II, which appears to be enriched at the nucleosome boundary 8 . The interplay between precise nucleosome positioning and locations of DNA-binding factor immediately suggests specific hypotheses for mechanistic studies.
AtAc-seq footprints infer factor occupancy genome wide
We reasoned that DNA sequences directly occupied by DNAbinding proteins are protected from transposition; the resulting sequence 'footprint' reveals the presence of a DNA-binding protein at each site, analogous to DNase digestion footprints 24 . At a specific CTCF-binding site on chromosome 1, we observed a clear footprint (a deep notch of ATAC-seq signal) similar to footprints seen with DNase-seq 25, 26 , at the precise location of the CTCF motif that coincides with the summit of the CTCF ChIP-seq signal in GM12878 cells (Fig. 4a) . We averaged ATAC-seq signal over all expected locations of CTCF within the genome and observed a well-stereotyped footprint (Fig. 4b) . Similar results were obtained for a variety of common TFs (Supplementary Fig. 8 ). We inferred the CTCF binding probability from motif consensus score, evolutionary conservation and ATAC-seq insertion data to generate a posterior probability of CTCF binding at all loci 27 (Fig. 4c) .
Results using ATAC-seq closely recapitulated ChIP-seq binding data in this cell line and compared favorably to DNase-based factor occupancy inference (Supplementary Fig. 9 ), suggesting that factor occupancy data can be extracted from these ATAC-seq data, which would allow reconstruction of regulatory networks.
AtAc-seq enables epigenomic analysis on clinical timescales
Because ATAC-seq is rapid, information rich and compatible with small numbers of cells, we reasoned it may serve as a powerful tool to look at aspects of an individual's epigenome on a timescale that would make its application to the clinic feasible. We applied ATAC-seq to assay the epigenome of a healthy volunteer's T cells obtained via standard serial blood draws. With rapid T-cell enrichment and sample handling protocols (Online Methods), the total required time from blood draw to sequencing was approximately 275 min (Fig. 5a) . We performed this procedure on three consecutive days (Fig. 5b) and investigated the ATAC-seq profile at the IL2 locus to show how regulatory information on an individual epigenome can be obtained. IL-2 is a key cytokine that drives T-cell growth and functions in inflammatory and autoimmune diseases 28 . Furthermore, distinct drugs [29] [30] [31] inhibit the activities of different TFs that bind putative IL2 enhancers in a context-dependent manner. One might wish to identify the causal TF pathway in order to rationally target inhibition without exposing the patient to drugs unlikely to serve the therapeutic goal of IL-2 blockade. ATAC-seq showed that in the proband's T cells, only nuclear factor of activated T cells (NFAT), but not two other drug targets, engaged IL2 (Fig. 5c) . Thus, ATAC-seq was able to provide clinically relevant information on the regulatory state of this individual. npg Using ATAC-seq footprints, we generated the occupancy profiles of 89 TFs in proband T cells, enabling systematic reconstruction of regulatory networks. With this personalized regulatory map, we compared the genomic distribution of the same 89 TFs between GM12878 and proband CD4 + T cells. TFs that exhibited large variation in distribution between T cells and B cells were enriched for T cell-specific factors (Fig. 5d) . This analysis showed that NFAT was differentially regulating, whereas canonical CTCF occupancy was highly correlated within these two cell types (Fig. 5d) . Supporting this interpretation, we noted specific loci where NFAT was localized to known T cell-specific genes such as CD28 and the uncharacterized large intergenic noncoding RNA RP11-229C3.2 ( Supplementary Fig. 10 ). Additionally, ATAC-seq of CD4 + and CD8 + T cells and monocytes isolated by FACS from a single blood draw created a map of accessible chromatin and demonstrated that ATAC-seq is compatible with cellular enrichment using surface markers (Supplementary Fig. 11 ). Separately, allele-specific chromatin accessibility has been shown to be particularly relevant to our understanding of human disease 32 . As a proof of principle we also used ATAC-seq to identify candidate allele-specific openchromatin regions within the GM12878 cell line ( Supplementary  Fig. 12 ). These results demonstrate the feasibility of generating detailed personalized gene regulatory networks from clinical samples, opening the door for future diagnostic applications. discussion ATAC-seq allows simultaneous interrogation of factor occupancy, nucleosome positions in regulatory sites, and chromatin accessibility genome wide by considering the position of insertion and the distribution of insert lengths captured during the transposition reaction. Although extant methods such as DNase-seq and MNase-seq can also provide this information, they each require separate assays with large cell numbers. ATAC-seq also provides insert-size fingerprints of biologically relevant genomic regions, which suggests that it captures information on chromatin compaction. We expect ATAC-seq to have broad applicability, to considerably add to the genomics toolkit and to improve our understanding of gene regulation, particularly when integrated with other powerful rare-cell techniques such as FACS or laser-capture microdissection and recent advancements in RNA-seq 33, 34 .
One potentially exciting application of ATAC-seq is to generate personal epigenomic profiles on a timescale compatible with clinical decision-making. We envision that when ATAC-seq is coupled with ongoing improvements to sequencing and analysis turnaround times, this technique will offer the possibility of a day-long turnaround time for a personal epigenomic map. Deeper analyses to generate global regulatory networks and other inferences will take additional time, and we anticipate that bioinformatic analyses-not the molecular biology or sequencing-will become the bottleneck of epigenomic studies in the future. As ATAC-seq is compatible with FACS, it may enable studies on carefully sorted and rare subpopulations from primary tissues. We expect that ATAC-seq can also be applied to study select cellular subpopulations at different points during development and aging and during the progression of human diseases, including cancer, autoimmunity and neuropsychiatric disorders. 
